---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-093570"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T07:05:00.535618+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# CERo Therapeutics receives Nasdaq delisting notice for MVLS non-compliance; appeals hearing requested

## Summary
- Nasdaq notified CERo on Oct 30, 2024 that it failed to regain compliance with $50M MVLS requirement by Oct 29 cure period.
- Delisting scheduled for Nov 8, 2024 unless stayed by appeal; CERo requested hearing on Oct 31, 2024.
- Hearing request automatically stays suspension of common stock trading pending panel decision.
- Company intends to present a compliance plan covering both MVLS and prior bid-price deficiency disclosed Oct 25, 2024.
- No assurance of favorable panel decision or ability to regain/maintain Nasdaq compliance.

## SEC filing metadata
- accession: 0001213900-24-093570
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390024093570/0001213900-24-093570-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390024093570/ea0219564-8k_cerothera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-093570
- JSON: https://secwatch.observer/filing/0001213900-24-093570.json
- Plain text: https://secwatch.observer/filing/0001213900-24-093570.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.